Global and United States Cell Line Development Equipment In-Depth Research Report 2017-2022
The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.
This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Cell Line Development Equipment industry.
Major Companies
American Type Culture Collection (ATCC) (U.S.)
Lonza Group AG (Switzerland)
Thermo Fisher Scientific, Inc. (U.S.)
GE Healthcare (U.K.)
Sigma-Aldrich Corporation (U.S.)
Selexis SA (Switzerland)
European Collection of Cell Cultures (ECACC) (U.K.)
Corning, Inc. (U.S.)
WuXi AppTec, Inc. (China)
Sartorious AG (Germany)
Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Main types of products
Cell Line Development Equipment Market, bycubators
Cell Line Development Equipment Market, byntrifuges
Cell Line Development Equipment Market, byoreactors
Cell Line Development Equipment Market, byorage Equipment
Cell Line Development Equipment Market, bytomated Systems
Cell Line Development Equipment Market, by Key Consumers
Bioproduction
Tissue Engineering & Regenerative Medicines
Toxicity Testing
Research
Drug Discovery
Others
This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Cell Line Development Equipment industry.
Major Companies
American Type Culture Collection (ATCC) (U.S.)
Lonza Group AG (Switzerland)
Thermo Fisher Scientific, Inc. (U.S.)
GE Healthcare (U.K.)
Sigma-Aldrich Corporation (U.S.)
Selexis SA (Switzerland)
European Collection of Cell Cultures (ECACC) (U.K.)
Corning, Inc. (U.S.)
WuXi AppTec, Inc. (China)
Sartorious AG (Germany)
Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Main types of products
Cell Line Development Equipment Market, bycubators
Cell Line Development Equipment Market, byntrifuges
Cell Line Development Equipment Market, byoreactors
Cell Line Development Equipment Market, byorage Equipment
Cell Line Development Equipment Market, bytomated Systems
Cell Line Development Equipment Market, by Key Consumers
Bioproduction
Tissue Engineering & Regenerative Medicines
Toxicity Testing
Research
Drug Discovery
Others
CHAPTER ONE GLOBAL CELL LINE DEVELOPMENT EQUIPMENT MARKET OVERVIEW
1.1 Global Cell Line Development Equipment Market Sales Volume Revenue and Price 2012-2017
1.2 Cell Line Development Equipment, by ubators 2012-2017
1.2.1 Global Cell Line Development Equipment Sales Market Share by ubators 2012-2017
1.2.2 Global Cell Line Development Equipment Revenue Market Share by ubators 2012-2017
1.2.3 Global Cell Line Development Equipment Price by ubators 2012-2017
1.2.4
1.2.5
1.3 Cell Line Development Equipment, by trifuges 2012-2017
1.3.1 Global Cell Line Development Equipment Sales Market Share by trifuges 2012-2017
1.3.2 Global Cell Line Development Equipment Revenue Market Share by trifuges 2012-2017
1.3.3 Global Cell Line Development Equipment Price by trifuges 2012-2017
1.3.4
1.3.5
1.4 Cell Line Development Equipment, by reactors 2012-2017
1.4.1 Global Cell Line Development Equipment Sales Market Share by reactors 2012-2017
1.4.2 Global Cell Line Development Equipment Revenue Market Share by reactors 2012-2017
1.4.3 Global Cell Line Development Equipment Price by reactors 2012-2017
1.4.4
1.4.5
1.5 Cell Line Development Equipment, by rage Equipment 2012-2017
1.5.1 Global Cell Line Development Equipment Sales Market Share by rage Equipment 2012-2017
1.5.2 Global Cell Line Development Equipment Revenue Market Share by rage Equipment 2012-2017
1.5.3 Global Cell Line Development Equipment Price by rage Equipment 2012-2017
1.5.4
1.5.5
1.6 Cell Line Development Equipment, by omated Systems 2012-2017
1.6.1 Global Cell Line Development Equipment Sales Market Share by omated Systems 2012-2017
1.6.2 Global Cell Line Development Equipment Revenue Market Share by omated Systems 2012-2017
1.6.3 Global Cell Line Development Equipment Price by omated Systems 2012-2017
1.6.4
1.6.5
CHAPTER TWO UNITED STATES CELL LINE DEVELOPMENT EQUIPMENT MARKET OVERVIEW
2.1 United States Cell Line Development Equipment Market Sales Volume Revenue and Price 2012-2017
2.2 Cell Line Development Equipment, by ubators 2012-2017
2.2.1 United States Cell Line Development Equipment Sales Market Share by ubators 2012-2017
2.2.2 United States Cell Line Development Equipment Revenue Market Share by ubators 2012-2017
2.2.3 United States Cell Line Development Equipment Price by ubators 2012-2017
2.2.4
2.2.5
2.3 Cell Line Development Equipment, by trifuges 2012-2017
2.3.1 United States Cell Line Development Equipment Sales Market Share by trifuges 2012-2017
2.3.2 United States Cell Line Development Equipment Revenue Market Share by trifuges 2012-2017
2.3.3 United States Cell Line Development Equipment Price by trifuges 2012-2017
2.3.4
2.3.5
2.4 Cell Line Development Equipment, by reactors 2012-2017
2.4.1 United States Cell Line Development Equipment Sales Market Share by reactors 2012-2017
2.4.2 United States Cell Line Development Equipment Revenue Market Share by reactors 2012-2017
2.4.3 United States Cell Line Development Equipment Price by reactors 2012-2017
2.4.4
2.4.5
2.5 Cell Line Development Equipment, by rage Equipment 2012-2017
2.5.1 United States Cell Line Development Equipment Sales Market Share by rage Equipment 2012-2017
2.5.2 United States Cell Line Development Equipment Revenue Market Share by rage Equipment 2012-2017
2.5.3 United States Cell Line Development Equipment Price by rage Equipment 2012-2017
2.5.4
2.5.5
2.6 Cell Line Development Equipment, by omated Systems 2012-2017
2.6.1 United States Cell Line Development Equipment Sales Market Share by omated Systems 2012-2017
2.6.2 United States Cell Line Development Equipment Revenue Market Share by omated Systems 2012-2017
2.6.3 United States Cell Line Development Equipment Price by omated Systems 2012-2017
2.6.4
2.6.5
CHAPTER THREE CELL LINE DEVELOPMENT EQUIPMENT BY REGIONS 2012-2017
3.1 Global Cell Line Development Equipment Sales Market Share by Regions 2012-2017
3.2 Global Cell Line Development Equipment Revenue Market Share by Regions 2012-2017
3.3 Global Cell Line Development Equipment Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East
CHAPTER FOUR GLOBAL CELL LINE DEVELOPMENT EQUIPMENT BY COMPANIES 2012-2017
4.1 Global Cell Line Development Equipment Sales Volume Market Share by Companies 2012-2017
4.2 Global Cell Line Development Equipment Revenue Share by Companies 2012-2017
4.3 Global Top Companies Cell Line Development Equipment Key Product Model and Market Performance
4.4 Global Top Companies Cell Line Development Equipment Key Target Consumers and Market Performance
CHAPTER FIVE UNITED STATES CELL LINE DEVELOPMENT EQUIPMENT BY COMPANIES 2012-2017
5.1 United States Cell Line Development Equipment Sales Volume Market Share by Companies 2012-2017
5.2 United States Cell Line Development Equipment Revenue Share by Companies 2012-2017
5.3 United States Top Companies Cell Line Development Equipment Key Product Model and Market Performance
5.4 United States Top Companies Cell Line Development Equipment Key Target Consumers and Market Performance
CHAPTER SIX GLOBAL CELL LINE DEVELOPMENT EQUIPMENT BY CONSUMER 2012-2017
6.1 Global Cell Line Development Equipment Sales Market Share by Consumer 2012-2017
6.2 Bioproduction
6.3 Tissue Engineering & Regenerative Medicines
6.4 Toxicity Testing
6.5 Research
6.6 Drug Discovery
6.7 Others
6.8 Consuming Habit and Preference
CHAPTER SEVEN GLOBAL CELL LINE DEVELOPMENT EQUIPMENT BY CONSUMER 2012-2017
7.1 Global Cell Line Development Equipment Sales Market Share by Consumer 2012-2017
7.2 Bioproduction
7.3 Tissue Engineering & Regenerative Medicines
7.4 Toxicity Testing
7.5 Research
7.6 Drug Discovery
7.7 Others
7.8 Consuming Habit and Preference
CHAPTER EIGHT TOP COMPANIES PROFILE
8.1 American Type Culture Collection (ATCC) (U.S.)
8.1.1 American Type Culture Collection (ATCC) (U.S.) Company Details and Competitors
8.1.2 American Type Culture Collection (ATCC) (U.S.) Key Cell Line Development Equipment Models and Performance
8.1.3 American Type Culture Collection (ATCC) (U.S.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.1.4 American Type Culture Collection (ATCC) (U.S.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.2 Lonza Group AG (Switzerland)
8.2.1 Lonza Group AG (Switzerland) Company Details and Competitors
8.2.2 Lonza Group AG (Switzerland) Key Cell Line Development Equipment Models and Performance
8.2.3 Lonza Group AG (Switzerland) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.2.4 Lonza Group AG (Switzerland) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.3 Thermo Fisher Scientific, Inc. (U.S.)
8.3.1 Thermo Fisher Scientific, Inc. (U.S.) Company Details and Competitors
8.3.2 Thermo Fisher Scientific, Inc. (U.S.) Key Cell Line Development Equipment Models and Performance
8.3.3 Thermo Fisher Scientific, Inc. (U.S.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.3.4 Thermo Fisher Scientific, Inc. (U.S.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.4 GE Healthcare (U.K.)
8.4.1 GE Healthcare (U.K.) Company Details and Competitors
8.4.2 GE Healthcare (U.K.) Key Cell Line Development Equipment Models and Performance
8.4.3 GE Healthcare (U.K.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.4.4 GE Healthcare (U.K.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.5 Sigma-Aldrich Corporation (U.S.)
8.5.1 Sigma-Aldrich Corporation (U.S.) Company Details and Competitors
8.5.2 Sigma-Aldrich Corporation (U.S.) Key Cell Line Development Equipment Models and Performance
8.5.3 Sigma-Aldrich Corporation (U.S.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.5.4 Sigma-Aldrich Corporation (U.S.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.6 Selexis SA (Switzerland)
8.6.1 Selexis SA (Switzerland) Company Details and Competitors
8.6.2 Selexis SA (Switzerland) Key Cell Line Development Equipment Models and Performance
8.6.3 Selexis SA (Switzerland) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.6.4 Selexis SA (Switzerland) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.7 European Collection of Cell Cultures (ECACC) (U.K.)
8.7.1 European Collection of Cell Cultures (ECACC) (U.K.) Company Details and Competitors
8.7.2 European Collection of Cell Cultures (ECACC) (U.K.) Key Cell Line Development Equipment Models and Performance
8.7.3 European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.7.4 European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.8 Corning, Inc. (U.S.)
8.8.1 Corning, Inc. (U.S.) Company Details and Competitors
8.8.2 Corning, Inc. (U.S.) Key Cell Line Development Equipment Models and Performance
8.8.3 Corning, Inc. (U.S.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.8.4 Corning, Inc. (U.S.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.9 WuXi AppTec, Inc. (China)
8.9.1 WuXi AppTec, Inc. (China) Company Details and Competitors
8.9.2 WuXi AppTec, Inc. (China) Key Cell Line Development Equipment Models and Performance
8.9.3 WuXi AppTec, Inc. (China) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.9.4 WuXi AppTec, Inc. (China) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.10 Sartorious AG (Germany)
8.10.1 Sartorious AG (Germany) Company Details and Competitors
8.10.2 Sartorious AG (Germany) Key Cell Line Development Equipment Models and Performance
8.10.3 Sartorious AG (Germany) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.10.4 Sartorious AG (Germany) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN
9.1 Cell Line Development Equipment Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 Cell Line Development Equipment Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment
CHAPTER TEN GLOBAL CELL LINE DEVELOPMENT EQUIPMENT MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Cell Line Development Equipment Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Cell Line Development Equipment Sales (K Units) Forecast by Regions (2017-2022)
10.3 Global Cell Line Development Equipment Sales (K Units) Forecast by Application (2017-2022)
10.4 Global Cell Line Development Equipment Sales (K Units) Forecast by ubators (2017-2022)
10.5 Global Cell Line Development Equipment Sales (K Units) Forecast by trifuges (2017-2022)
10.6 Global Cell Line Development Equipment Sales (K Units) Forecast by reactors (2017-2022)
10.7 Global Cell Line Development Equipment Sales (K Units) Forecast by rage Equipment (2017-2022)
10.8 Global Cell Line Development Equipment Sales (K Units) Forecast by omated Systems (2017-2022)
CHAPTER ELEVEN UNITED STATES CELL LINE DEVELOPMENT EQUIPMENT MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 United States Cell Line Development Equipment Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Cell Line Development Equipment Sales (K Units) Forecast by Regions (2017-2022)
11.3 United States Cell Line Development Equipment Sales (K Units) Forecast by Application (2017-2022)
11.4 United States Cell Line Development Equipment Sales (K Units) Forecast by ubators (2017-2022)
11.5 United States Cell Line Development Equipment Sales (K Units) Forecast by trifuges (2017-2022)
11.6 United States Cell Line Development Equipment Sales (K Units) Forecast by reactors (2017-2022)
11.7 United States Cell Line Development Equipment Sales (K Units) Forecast by rage Equipment (2017-2022)
11.8 United States Cell Line Development Equipment Sales (K Units) Forecast by omated Systems (2017-2022)
CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION
12.1 Development Trend
12.2 Research Conclusion
CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
1.1 Global Cell Line Development Equipment Market Sales Volume Revenue and Price 2012-2017
1.2 Cell Line Development Equipment, by ubators 2012-2017
1.2.1 Global Cell Line Development Equipment Sales Market Share by ubators 2012-2017
1.2.2 Global Cell Line Development Equipment Revenue Market Share by ubators 2012-2017
1.2.3 Global Cell Line Development Equipment Price by ubators 2012-2017
1.2.4
1.2.5
1.3 Cell Line Development Equipment, by trifuges 2012-2017
1.3.1 Global Cell Line Development Equipment Sales Market Share by trifuges 2012-2017
1.3.2 Global Cell Line Development Equipment Revenue Market Share by trifuges 2012-2017
1.3.3 Global Cell Line Development Equipment Price by trifuges 2012-2017
1.3.4
1.3.5
1.4 Cell Line Development Equipment, by reactors 2012-2017
1.4.1 Global Cell Line Development Equipment Sales Market Share by reactors 2012-2017
1.4.2 Global Cell Line Development Equipment Revenue Market Share by reactors 2012-2017
1.4.3 Global Cell Line Development Equipment Price by reactors 2012-2017
1.4.4
1.4.5
1.5 Cell Line Development Equipment, by rage Equipment 2012-2017
1.5.1 Global Cell Line Development Equipment Sales Market Share by rage Equipment 2012-2017
1.5.2 Global Cell Line Development Equipment Revenue Market Share by rage Equipment 2012-2017
1.5.3 Global Cell Line Development Equipment Price by rage Equipment 2012-2017
1.5.4
1.5.5
1.6 Cell Line Development Equipment, by omated Systems 2012-2017
1.6.1 Global Cell Line Development Equipment Sales Market Share by omated Systems 2012-2017
1.6.2 Global Cell Line Development Equipment Revenue Market Share by omated Systems 2012-2017
1.6.3 Global Cell Line Development Equipment Price by omated Systems 2012-2017
1.6.4
1.6.5
CHAPTER TWO UNITED STATES CELL LINE DEVELOPMENT EQUIPMENT MARKET OVERVIEW
2.1 United States Cell Line Development Equipment Market Sales Volume Revenue and Price 2012-2017
2.2 Cell Line Development Equipment, by ubators 2012-2017
2.2.1 United States Cell Line Development Equipment Sales Market Share by ubators 2012-2017
2.2.2 United States Cell Line Development Equipment Revenue Market Share by ubators 2012-2017
2.2.3 United States Cell Line Development Equipment Price by ubators 2012-2017
2.2.4
2.2.5
2.3 Cell Line Development Equipment, by trifuges 2012-2017
2.3.1 United States Cell Line Development Equipment Sales Market Share by trifuges 2012-2017
2.3.2 United States Cell Line Development Equipment Revenue Market Share by trifuges 2012-2017
2.3.3 United States Cell Line Development Equipment Price by trifuges 2012-2017
2.3.4
2.3.5
2.4 Cell Line Development Equipment, by reactors 2012-2017
2.4.1 United States Cell Line Development Equipment Sales Market Share by reactors 2012-2017
2.4.2 United States Cell Line Development Equipment Revenue Market Share by reactors 2012-2017
2.4.3 United States Cell Line Development Equipment Price by reactors 2012-2017
2.4.4
2.4.5
2.5 Cell Line Development Equipment, by rage Equipment 2012-2017
2.5.1 United States Cell Line Development Equipment Sales Market Share by rage Equipment 2012-2017
2.5.2 United States Cell Line Development Equipment Revenue Market Share by rage Equipment 2012-2017
2.5.3 United States Cell Line Development Equipment Price by rage Equipment 2012-2017
2.5.4
2.5.5
2.6 Cell Line Development Equipment, by omated Systems 2012-2017
2.6.1 United States Cell Line Development Equipment Sales Market Share by omated Systems 2012-2017
2.6.2 United States Cell Line Development Equipment Revenue Market Share by omated Systems 2012-2017
2.6.3 United States Cell Line Development Equipment Price by omated Systems 2012-2017
2.6.4
2.6.5
CHAPTER THREE CELL LINE DEVELOPMENT EQUIPMENT BY REGIONS 2012-2017
3.1 Global Cell Line Development Equipment Sales Market Share by Regions 2012-2017
3.2 Global Cell Line Development Equipment Revenue Market Share by Regions 2012-2017
3.3 Global Cell Line Development Equipment Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East
CHAPTER FOUR GLOBAL CELL LINE DEVELOPMENT EQUIPMENT BY COMPANIES 2012-2017
4.1 Global Cell Line Development Equipment Sales Volume Market Share by Companies 2012-2017
4.2 Global Cell Line Development Equipment Revenue Share by Companies 2012-2017
4.3 Global Top Companies Cell Line Development Equipment Key Product Model and Market Performance
4.4 Global Top Companies Cell Line Development Equipment Key Target Consumers and Market Performance
CHAPTER FIVE UNITED STATES CELL LINE DEVELOPMENT EQUIPMENT BY COMPANIES 2012-2017
5.1 United States Cell Line Development Equipment Sales Volume Market Share by Companies 2012-2017
5.2 United States Cell Line Development Equipment Revenue Share by Companies 2012-2017
5.3 United States Top Companies Cell Line Development Equipment Key Product Model and Market Performance
5.4 United States Top Companies Cell Line Development Equipment Key Target Consumers and Market Performance
CHAPTER SIX GLOBAL CELL LINE DEVELOPMENT EQUIPMENT BY CONSUMER 2012-2017
6.1 Global Cell Line Development Equipment Sales Market Share by Consumer 2012-2017
6.2 Bioproduction
6.3 Tissue Engineering & Regenerative Medicines
6.4 Toxicity Testing
6.5 Research
6.6 Drug Discovery
6.7 Others
6.8 Consuming Habit and Preference
CHAPTER SEVEN GLOBAL CELL LINE DEVELOPMENT EQUIPMENT BY CONSUMER 2012-2017
7.1 Global Cell Line Development Equipment Sales Market Share by Consumer 2012-2017
7.2 Bioproduction
7.3 Tissue Engineering & Regenerative Medicines
7.4 Toxicity Testing
7.5 Research
7.6 Drug Discovery
7.7 Others
7.8 Consuming Habit and Preference
CHAPTER EIGHT TOP COMPANIES PROFILE
8.1 American Type Culture Collection (ATCC) (U.S.)
8.1.1 American Type Culture Collection (ATCC) (U.S.) Company Details and Competitors
8.1.2 American Type Culture Collection (ATCC) (U.S.) Key Cell Line Development Equipment Models and Performance
8.1.3 American Type Culture Collection (ATCC) (U.S.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.1.4 American Type Culture Collection (ATCC) (U.S.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.2 Lonza Group AG (Switzerland)
8.2.1 Lonza Group AG (Switzerland) Company Details and Competitors
8.2.2 Lonza Group AG (Switzerland) Key Cell Line Development Equipment Models and Performance
8.2.3 Lonza Group AG (Switzerland) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.2.4 Lonza Group AG (Switzerland) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.3 Thermo Fisher Scientific, Inc. (U.S.)
8.3.1 Thermo Fisher Scientific, Inc. (U.S.) Company Details and Competitors
8.3.2 Thermo Fisher Scientific, Inc. (U.S.) Key Cell Line Development Equipment Models and Performance
8.3.3 Thermo Fisher Scientific, Inc. (U.S.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.3.4 Thermo Fisher Scientific, Inc. (U.S.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.4 GE Healthcare (U.K.)
8.4.1 GE Healthcare (U.K.) Company Details and Competitors
8.4.2 GE Healthcare (U.K.) Key Cell Line Development Equipment Models and Performance
8.4.3 GE Healthcare (U.K.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.4.4 GE Healthcare (U.K.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.5 Sigma-Aldrich Corporation (U.S.)
8.5.1 Sigma-Aldrich Corporation (U.S.) Company Details and Competitors
8.5.2 Sigma-Aldrich Corporation (U.S.) Key Cell Line Development Equipment Models and Performance
8.5.3 Sigma-Aldrich Corporation (U.S.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.5.4 Sigma-Aldrich Corporation (U.S.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.6 Selexis SA (Switzerland)
8.6.1 Selexis SA (Switzerland) Company Details and Competitors
8.6.2 Selexis SA (Switzerland) Key Cell Line Development Equipment Models and Performance
8.6.3 Selexis SA (Switzerland) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.6.4 Selexis SA (Switzerland) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.7 European Collection of Cell Cultures (ECACC) (U.K.)
8.7.1 European Collection of Cell Cultures (ECACC) (U.K.) Company Details and Competitors
8.7.2 European Collection of Cell Cultures (ECACC) (U.K.) Key Cell Line Development Equipment Models and Performance
8.7.3 European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.7.4 European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.8 Corning, Inc. (U.S.)
8.8.1 Corning, Inc. (U.S.) Company Details and Competitors
8.8.2 Corning, Inc. (U.S.) Key Cell Line Development Equipment Models and Performance
8.8.3 Corning, Inc. (U.S.) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.8.4 Corning, Inc. (U.S.) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.9 WuXi AppTec, Inc. (China)
8.9.1 WuXi AppTec, Inc. (China) Company Details and Competitors
8.9.2 WuXi AppTec, Inc. (China) Key Cell Line Development Equipment Models and Performance
8.9.3 WuXi AppTec, Inc. (China) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.9.4 WuXi AppTec, Inc. (China) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
8.10 Sartorious AG (Germany)
8.10.1 Sartorious AG (Germany) Company Details and Competitors
8.10.2 Sartorious AG (Germany) Key Cell Line Development Equipment Models and Performance
8.10.3 Sartorious AG (Germany) Cell Line Development Equipment Business SWOT Analysis and Forecast
8.10.4 Sartorious AG (Germany) Cell Line Development Equipment Sales Volume Revenue Price Cost and Gross Margin
CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN
9.1 Cell Line Development Equipment Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 Cell Line Development Equipment Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment
CHAPTER TEN GLOBAL CELL LINE DEVELOPMENT EQUIPMENT MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Cell Line Development Equipment Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Cell Line Development Equipment Sales (K Units) Forecast by Regions (2017-2022)
10.3 Global Cell Line Development Equipment Sales (K Units) Forecast by Application (2017-2022)
10.4 Global Cell Line Development Equipment Sales (K Units) Forecast by ubators (2017-2022)
10.5 Global Cell Line Development Equipment Sales (K Units) Forecast by trifuges (2017-2022)
10.6 Global Cell Line Development Equipment Sales (K Units) Forecast by reactors (2017-2022)
10.7 Global Cell Line Development Equipment Sales (K Units) Forecast by rage Equipment (2017-2022)
10.8 Global Cell Line Development Equipment Sales (K Units) Forecast by omated Systems (2017-2022)
CHAPTER ELEVEN UNITED STATES CELL LINE DEVELOPMENT EQUIPMENT MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 United States Cell Line Development Equipment Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Cell Line Development Equipment Sales (K Units) Forecast by Regions (2017-2022)
11.3 United States Cell Line Development Equipment Sales (K Units) Forecast by Application (2017-2022)
11.4 United States Cell Line Development Equipment Sales (K Units) Forecast by ubators (2017-2022)
11.5 United States Cell Line Development Equipment Sales (K Units) Forecast by trifuges (2017-2022)
11.6 United States Cell Line Development Equipment Sales (K Units) Forecast by reactors (2017-2022)
11.7 United States Cell Line Development Equipment Sales (K Units) Forecast by rage Equipment (2017-2022)
11.8 United States Cell Line Development Equipment Sales (K Units) Forecast by omated Systems (2017-2022)
CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION
12.1 Development Trend
12.2 Research Conclusion
CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES AND FIGURES
Table Global Cell Line Development Equipment Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global Cell Line Development Equipment Revenue (Million USD) and Gr
Table Global Cell Line Development Equipment Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global Cell Line Development Equipment Revenue (Million USD) and Gr
